相关实验视频
Updated: Jul 7, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
黑色素瘤亚型的回顾:遗传和治疗考虑因素
Christina Druskovich1, Jesse Kelley2, Jason Aubrey2
1College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
Journal of surgical oncology
|October 17, 2024
概括
这次审查强调了黑色素瘤亚型表现出明显的遗传突变和预后. 了解这些差异,就像结节性黑色素瘤中常见的BRAF突变一样,对于有效的患者治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 皮肤病学 皮肤病学
背景情况:
- 黑色素瘤在美国影响超过一百万个人.
- 有七种不同的黑色素瘤亚型,每个都有独特的特征.
- 遗传突变和预后变异性需要特定于亚型的方法.
研究的目的:
- 审查所有七种黑色素瘤亚型中的遗传突变和标记.
- 讨论每种亚型的当前治疗选择和预后.
- 强调在治疗决策中考虑黑色素瘤亚型的重要性.
主要方法:
- 对黑色素瘤亚型中的遗传突变和标记物的文献综述.
- 对治疗策略和患者结果的分析.
- 七种黑色素瘤亚型的比较研究.
主要成果:
- 在lentigo恶性,spitzoid和结节性黑色素瘤中,BRAF突变很常见.
- 在表面传播黑色素瘤中,TP53突变最常见.
- 阿克拉性状黑色素瘤经常表现出CCDN1和desmoplastic NF1突变;无状黑色素瘤没有发现突变.
- 结节性黑色素瘤具有最高的死亡率.
结论:
- 黑色素瘤亚型在遗传特征,治疗反应和预后方面存在显著差异.
- 亚型分类对于定制黑色素瘤治疗策略至关重要.
- 建议采用个性化医疗方法,考虑黑色素瘤亚型.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

